Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04032418
Brief Title: Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer

First Submitted : July 18, 2019
First Submitted that Met QC Criteria : July 19, 2019
First Posted : July 25, 2019

Last Update Submitted that Met QC Criteria : February 17, 2021
Last Update Posted : February 21, 2021